U.S., June 6 -- ClinicalTrials.gov registry received information related to the study (NCT07630402) titled 'Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer' on June 01.
Brief Summary: The purpose of this study is to determine whether a personalized, risk-stratified surveillance strategy can safely reduce unnecessary cardiac imaging while preserving early detection of treatment-related cardiotoxicity in women with breast cancer (BC) receiving HER2-targeted therapy (HER2-TT).
Study Start Date: Nov. 17, 2025
Study Type: INTERVENTIONAL
Condition:
Breast Cancer With Low to Intermediate HER2 Expression
Intervention:
PROCEDURE: Echocardiogram
12-lead echocardiogram
Recruitment Status: RECRUITING
Sponsor: Universit...